Myomo Reports Third Quarter 2026 Financial and Operating Results
Business Wire•09/11/2026•16:05 ET
0
Key Highlights
- ➤Q3 revenue reached $12.3 million, up 22% year over year
- ➤Full-year revenue guidance narrowed to $46-47 million, upper end of previous guidance
- ➤Adjusted EBITDA reached breakeven versus a $2.7 million loss last year
- ➤Gross margin expanded to 71.3%, up 750 basis points year over year
- ➤Recurring patient sources generated 54% of Q3 revenue, up from 33%
Expert Statements
Paul R. Gudonis, Chairman and Chief Executive Officer of Myomo
“The focus on our four success pillars helped deliver record revenue and solid operating leverage in the quarter, resulting in breakeven Adjusted EBITDA and sequentially lower cash burn”
Paul R. Gudonis, Chairman and Chief Executive Officer of Myomo
“Third quarter revenue places us on track to achieve the midpoint or better of our raised guidance from last quarter. In addition, I am pleased to report that our MyoConnect program now exceeds 500 referral locations in the U.S., helping to drive revenue from recurring sources.”
Paul R. Gudonis, Chairman and Chief Executive Officer of Myomo
“We raised our full year revenue guidance last quarter, and today we are updating that revenue guidance to be in the upper half of that range”
Paul R. Gudonis, Chairman and Chief Executive Officer of Myomo
“We also reiterate our full year operating leverage expectation, and we continue to expect cash burn to be less than $2 million during the second half of the year”
Myomo Reports Third Quarter 2026 Financial and Operating Results
Record revenue of $12.3 million, increased 22% year over year
Get started
Create a free account to read the full story.